215 related articles for article (PubMed ID: 37212330)
1. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ; Chin RFM
Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
[TBL] [Abstract][Full Text] [Related]
2. Anti-seizure medications for Lennox-Gastaut syndrome.
Brigo F; Jones K; Eltze C; Matricardi S
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
[TBL] [Abstract][Full Text] [Related]
3. Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ; Chin RFM
Expert Rev Neurother; 2024 Mar; 24(3):235-249. PubMed ID: 38315124
[TBL] [Abstract][Full Text] [Related]
4. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S
Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898
[TBL] [Abstract][Full Text] [Related]
5. Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis.
Devi N; Madaan P; Ameen R; Sahu JK; Bansal D
Seizure; 2022 Jul; 99():164-175. PubMed ID: 35487871
[TBL] [Abstract][Full Text] [Related]
6. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2021 Jan; 35(1):61-83. PubMed ID: 33479851
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
[TBL] [Abstract][Full Text] [Related]
8. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis.
Zhang L; Wang J; Wang C
Dev Med Child Neurol; 2022 Mar; 64(3):305-313. PubMed ID: 34590711
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ
Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
[No Abstract] [Full Text] [Related]
11. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.
Samanta D
Epilepsy Behav; 2021 Jan; 114(Pt A):107612. PubMed ID: 33243685
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
Montouris GD; Wheless JW; Glauser TA
Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
[TBL] [Abstract][Full Text] [Related]
13. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
[TBL] [Abstract][Full Text] [Related]
14. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
Cramer JA; Sapin C; François C
Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
Sharawat IK; Panda PK; Panda P; Dawman L
Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
[TBL] [Abstract][Full Text] [Related]
17. Lennox-Gastaut syndrome: a comprehensive review.
Asadi-Pooya AA
Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
[TBL] [Abstract][Full Text] [Related]
18. Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials.
Bialer M; Perucca E
Epilepsia; 2020 Jun; 61(6):1082-1089. PubMed ID: 32452568
[TBL] [Abstract][Full Text] [Related]
19. A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA).
Hahn CD; Jiang Y; Villanueva V; Zolnowska M; Arkilo D; Hsiao S; Asgharnejad M; Dlugos D
Epilepsia; 2022 Oct; 63(10):2671-2683. PubMed ID: 35841234
[TBL] [Abstract][Full Text] [Related]
20. Lennox-Gastaut syndrome: New treatments and treatments under investigation.
Auvin S
Rev Neurol (Paris); 2020 Jun; 176(6):444-447. PubMed ID: 32409177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]